TH1701003724A - Pharmaceutical constituents for cancer treatment containing metal lactate salts. - Google Patents

Pharmaceutical constituents for cancer treatment containing metal lactate salts.

Info

Publication number
TH1701003724A
TH1701003724A TH1701003724A TH1701003724A TH1701003724A TH 1701003724 A TH1701003724 A TH 1701003724A TH 1701003724 A TH1701003724 A TH 1701003724A TH 1701003724 A TH1701003724 A TH 1701003724A TH 1701003724 A TH1701003724 A TH 1701003724A
Authority
TH
Thailand
Prior art keywords
containing metal
cancer treatment
treatment containing
lactate salts
metal lactate
Prior art date
Application number
TH1701003724A
Other languages
Thai (th)
Inventor
คิม
มุก ฮวาน
จอง
ยอง คึน
ชิม
จุน แจ
จาง
ซู ยึน
Original Assignee
นางสาวเสาวลักษณ์ ล้ำเลิศ
นางสาวจิตชนก สารรักษ์
นายประดิพล เครือแก้ว
Filing date
Publication date
Application filed by นางสาวเสาวลักษณ์ ล้ำเลิศ, นางสาวจิตชนก สารรักษ์, นายประดิพล เครือแก้ว filed Critical นางสาวเสาวลักษณ์ ล้ำเลิศ
Publication of TH1701003724A publication Critical patent/TH1701003724A/en

Links

Abstract

สิทธิบัตรยา Drug patent

Claims (1)

: ข้อถือสิทธิ์ (ข้อที่หนึ่ง) ซึ่งจะปรากฏบนหน้าประกาศโฆษณา : แก้ไข 15 พ.ค. 2563 ไม่มีข้อถือสิทธิ -------------------------------------------------------------------------- แก้ไข 01/04/2562: Privilege (item one) which will appear on the advertisement page: Amendment 15 May 2020 No disclaimers -------------------------------------------------- ------------------------ Edit 01/04/2019 1. องค์ประกอบทางเภสัชกรรมสำหรับการรักษามะเร็งที่ประกอบรวมด้วยเกลือแลคเทตของ โลหะเป็นส่วนประกอบออกฤทธิ์ -----------------------แท็ก : สิทธิบัตรยา1. The pharmaceutical components for the treatment of cancer that contain lactate salt of Metal is an active ingredient. ----------------------- Tag: drug patent
TH1701003724A 2015-12-04 Pharmaceutical constituents for cancer treatment containing metal lactate salts. TH1701003724A (en)

Publications (1)

Publication Number Publication Date
TH1701003724A true TH1701003724A (en) 2020-05-25

Family

ID=

Similar Documents

Publication Publication Date Title
TH1701003724A (en) Pharmaceutical constituents for cancer treatment containing metal lactate salts.
TH178555A (en) Heteroerril derivatives Or its pharmaceutical acceptable salt, method of preparation, and pharmaceutical constituents for the prevention or treatment of disease. Associated with PI3 kinase, which has the same thing as active ingredient.
TH1601005830A (en) Substances for controlling melatonin secretion and methods for controlling melatonin secretion
TH1801001591A (en) Therapeutic or prophylactic agents of fungal cornealitis
TH166749B (en) New pyrolopyrimidine compounds Or salt of that substance Pharmaceuticals containing the same substance, in particular for the prevention and / or treatment of tumors and others that rely on NAE inhibitory effects.
TH1801001808A (en) An isoindolinone inhibitor of MDM2-P53 interaction with anticancer activity.
TH178547A (en) Preventive and / or therapeutic agents of immune-related diseases
TH1501005024A (en) Pharmaceutical constituents for the treatment of fungal infections.
TH167583A (en) Carboxamide derivatives
TH1601006980A (en)
TH166749A (en) New pyrolopyrimidine compounds Or salt of that substance Pharmaceuticals containing the same substance, in particular for the prevention and / or treatment of tumors and others that rely on NAE inhibitory effects.
TH166748A (en) Macro cyclic pyrimidine derivatives
TH1901001876A (en) Please love pyrimidine for the treatment of viral infections and other diseases.
TH1701002032A (en) The use of neridronic acid or its salts for the treatment of osteomyelitis.
TH168999A (en) Inhibitors of RORC2 type heterobyclo-arylate And how to use it
TH182546A (en) Pharmaceutical components for prevention And the treatment of liver disease with chromolin Or salts of this substance acceptable in a pharmaceutical compound as an active ingredient
EA201992619A2 (en) PPAR AGONISTS, COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND WAYS OF THEIR APPLICATION
TH1701003010A (en) Components for the treatment of schizophrenia
TH141824A (en) Liver function enhancer
TH1701001398A (en) 1-alkyl-6-oxo-1,6-dihydropyridin-3-il compounds And using it as a SGRM controller
TH171941A (en) New awakening agent of soluble guanylate cyclase And the use of that substance
TH1701003135A (en) Composition and methods of medium-chain triglyceride for the treatment of epilepsy.
TH1701003406A (en) Pharmaceutical formulation of tropomieosin-related kinase inhibitors (TRK).
TH169293A (en) BACEI inhibitors
TH1701007409A (en) Benzoxepin oxasolidinone compounds and methods of use